Glucagonoma MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 7: | Line 7: | ||
==MRI== | ==MRI== | ||
*Findings on abdominal MRI suggestive of glucagonoma include: | *Findings on abdominal MRI suggestive of glucagonoma include:<ref name="pmid25789004">{{cite journal| author=Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO| title=Imaging features of glucagonoma syndrome: A case report and review of the literature. | journal=Oncol Lett | year= 2015 | volume= 9 | issue= 4 | pages= 1579-1582 | pmid=25789004 | doi=10.3892/ol.2015.2930 | pmc=PMC4356379 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25789004 }} </ref> | ||
**T1: low signal intensity | **T1: low signal intensity | ||
**T2: high signal intensity | **T2: high signal intensity | ||
Revision as of 16:03, 20 November 2017
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma MRI On the Web |
|
American Roentgen Ray Society Images of Glucagonoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]
Overview
Abdominal MRI is helpful in the diagnosis of glucagonoma. On abdominal MRI, glucagonoma is characterized by a mass which is hypointense on T1-weighted MRI and hyper-intense on T2-weighted MRI. MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis.
MRI
- Findings on abdominal MRI suggestive of glucagonoma include:[1]
- T1: low signal intensity
- T2: high signal intensity
- MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy hy for assessing metastasis.
References
- ↑ Lv WF, Han JK, Liu X, Wang SC, Pan BO, Xu AO (2015). "Imaging features of glucagonoma syndrome: A case report and review of the literature". Oncol Lett. 9 (4): 1579–1582. doi:10.3892/ol.2015.2930. PMC 4356379. PMID 25789004.